Harvey Cushing's early treatment of meningiomas: the untold story

Courtney Pendleton1, Alessandro Olivi, Henry Brem

  • 1Department of Neurosurgery and Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

World Neurosurgery
|November 29, 2011
PubMed

Insights

Harvey Cushing’s early meningioma surgeries at Johns Hopkins Hospital showed his focus on hemostasis and staged resections for large tumors, though early outcomes were poor.

Area of Science:

  • Neurosurgery
  • Surgical History
  • Oncology

Background:

  • Review of Harvey Cushing's early meningioma cases (1896-1912) at Johns Hopkins Hospital.
  • Analysis of 18 meningioma patients treated by Cushing, with detailed operative descriptions previously unavailable.
  • Focus on cases diagnosed as endothelioma or dural endothelioma.

Discussion:

  • Cushing's surgical techniques evolved, demonstrating early attention to hemostasis.
  • Staged resections were employed for large, highly vascular meningiomas to mitigate risks.
  • Limited success in reducing morbidity and mortality in these early cases.

Key Insights:

  • Early meningioma surgeries by Cushing highlight his meticulous approach to hemostasis.
  • Staged resection strategies were developed in response to challenging tumor characteristics.
  • High inpatient mortality (64.3%) underscores the difficulties in treating meningiomas during this era.

Outlook:

  • These early cases illustrate Cushing's adaptive surgical strategies and problem-solving abilities.
  • Understanding Cushing's foundational techniques provides historical context for modern meningioma treatment.
  • Further research could explore the long-term outcomes of these specific patient cohorts.
Abstract

Related Concept Videos

Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Psychosurgery01:30

Psychosurgery

Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...